1Johansson, E, Lonnroth, I, Lange, S, et al. (1995) Molecular cloning and expression of a pituitary gland protein modulating intestinal fluid secretion. J Biol Chem 270, 20615–20620.
2Davidson, TS & Hickey, WF (2004) Antisecretory factor expression is regulated by inflammatory mediators and influences the severity of experimental autoimmune encephalomyelitis. J Leukoc Biol 76, 835–844.
3Davidson, TS & Hickey, WF (2004) Distribution and immunoregulatory properties of antisecretory factor. Lab Invest 84, 307–319.
4Ulgheri, C, Paganini, B & Rossi, F (2010) Antisecretory factor as a potential health-promoting molecule in man and animals. Nutr Res Rev 23, 300–313.
5Mañé, J, Lorén, V, Pedrosa, E, et al. (2011) Therapeutic effect of antisecretory factor-rich egg yolk on the late phases of 2,4,6-trinitrobenzenesulphonic acid colitis in mice. Br J Nutr 106, 1522–1528.
6Eriksson, A, Shafazand, M, Jennische, E, et al. (2003) Effect of antisecretory factor in ulcerative colitis on histological and laborative outcome: a short period clinical trial. Scand J Gastroenterol 38, 1045–1049.
7Johansson, E, Lonnroth, I, Jonson, I, et al. (2009) Development of monoclonal antibodies for detection of antisecretory factor activity in human plasma. J Immunol Methods 342, 64–70.
8Bjorck, S, Bosaeus, I, Ek, E, et al. (2000) Food induced stimulation of the antisecretory factor can improve symptoms in human inflammatory bowel disease: a study of a concept. Gut 46, 824–829.
9Hanner, P, Rask-Andersen, H, Lange, S, et al. (2010) Antisecretory factor-inducing therapy improves the clinical outcome in patients with Meniere's disease. Acta Otolaryngol 130, 223–227.
10Johansson, E, Lange, S & Jennische, E (2011) Specially processed cereals diet increases plasma levels of active antisecretory factor and up-regulates rat hepatic glutathione S-transferase mu. Nutrition 27, 949–954.
11Saljo, A, Bolouri, H, Mayorga, M, et al. (2010) Low-level blast raises intracranial pressure and impairs cognitive function in rats: prophylaxis with processed cereal feed. J Neurotrauma 27, 383–389.
12Schneider, GH, Hennig, S, Lanksch, WR, et al. (1994) Dynamics of posttraumatic brain swelling following a cryogenic injury in rats. Acta Neurochir Suppl (Wien) 60, 437–439.
13Jennische, E, Bergstrom, T, Johansson, M, et al. (2008) The peptide AF-16 abolishes sickness and death at experimental encephalitis by reducing increase of intracranial pressure. Brain Res 1227, 189–197.
14Palarasah, Y, Skjodt, K, Brandt, J, et al. (2010) Generation of a C3c specific monoclonal antibody and assessment of C3c as a putative inflammatory marker derived from complement factor C3. J Immunol Methods 362, 142–150.
15Lange, S & Lonnroth, I (2001) The antisecretory factor: synthesis, anatomical and cellular distribution, and biological action in experimental and clinical studies. Int Rev Cytol 210, 39–75.
16Lonnroth, I & Lange, S (1987) Intake of monosaccharides or amino acids induces pituitary gland synthesis of proteins regulating intestinal fluid transport. Biochim Biophys Acta 925, 117–123.
17Hanner, P, Jennische, E, Lange, S, et al. (2004) Increased antisecretory factor reduces vertigo in patients with Meniere's disease: a pilot study. Hear Res 190, 31–36.
18Flach, CF, Lange, S, Jennische, E, et al. (2004) Cholera toxin induces expression of ion channels and carriers in rat small intestinal mucosa. FEBS Lett 561, 122–126.
19Kim, M, Wasling, P, Xiao, MY, et al. (2005) Antisecretory factor modulates GABAergic transmission in the rat hippocampus. Regul Pept 129, 109–118.
20Johansson, E, Jennische, E, Lange, S, et al. (1997) Antisecretory factor suppresses intestinal inflammation and hypersecretion. Gut 41, 642–645.
21Al-Olama, M, Wallgren, A, Andersson, B, et al. (2011) The peptide AF-16 decreases high interstitial fluid pressure in solid tumors. Acta Oncol 50, 1098–1104.
22Graber, DJ, Harris, BT & Hickey, WF (2011) Strain-dependent variation in the early transcriptional response to CNS injury using a cortical explant system. J Neuroinflammation 8, 122.
23Schmidt, OI, Heyde, CE, Ertel, W, et al. (2005) Closed head injury – an inflammatory disease? Brain Res Brain Res Rev 48, 388–399.
24Simard, JM, Kent, TA, Chen, M, et al. (2007) Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol 6, 258–268.
25Strbian, D, Kovanen, PT, Karjalainen-Lindsberg, ML, et al. (2009) An emerging role of mast cells in cerebral ischemia and hemorrhage. Ann Med 41, 438–450.
26Knerlich, F, Schilling, L, Gorlach, C, et al. (1999) Temporal profile of expression and cellular localization of inducible nitric oxide synthase, interleukin-1beta and interleukin converting enzyme after cryogenic lesion of the rat parietal cortex. Brain Res Mol Brain Res 68, 73–87.
27Cherian, L, Hlatky, R & Robertson, CS (2004) Nitric oxide in traumatic brain injury. Brain Pathol 14, 195–201.
28Terpolilli, NA, Zweckberger, K, Trabold, R, et al. (2009) The novel nitric oxide synthase inhibitor 4-amino-tetrahydro-l-biopterine prevents brain edema formation and intracranial hypertension following traumatic brain injury in mice. J Neurotrauma 26, 1963–1975.